BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20957222)

  • 1. Synthesis and evaluation of nanoglobule-cystamine-(Gd-DO3A), a biodegradable nanosized magnetic resonance contrast agent for dynamic contrast-enhanced magnetic resonance urography.
    Xu R; Kaneshiro TL; Jeong EK; Parker DL; Lu ZR
    Int J Nanomedicine; 2010 Sep; 5():707-13. PubMed ID: 20957222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
    Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.
    Ke T; Feng Y; Guo J; Parker DL; Lu ZR
    Magn Reson Imaging; 2006 Sep; 24(7):931-40. PubMed ID: 16916710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
    Wang X; Feng Y; Ke T; Schabel M; Lu ZR
    Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
    Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
    Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging.
    Lu ZR; Wang X; Parker DL; Goodrich KC; Buswell HR
    Bioconjug Chem; 2003; 14(4):715-9. PubMed ID: 12862423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.
    Ke T; Jeong EK; Wang X; Feng Y; Parker DL; Lu ZR
    Int J Nanomedicine; 2007; 2(2):191-9. PubMed ID: 17722547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
    Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
    Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
    Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
    Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
    Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
    Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
    Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
    Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
    Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
    Runge VM
    J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.